Taken together, these findings suggest that NOP2-mediated m5C methylation of APOL1 mRNA regulates the PI3K/Akt signaling pathway and may serve as a novel mechanism for ccRCC progression. The gene discussed is NOP2; the disease is nonpapillary renal cell carcinoma.